title: A phase I clinical trial of flavone-8-acetic acid in combination with interleukin 2.
authors.affiliation: Clinical Research Branch, National Cancer Institute-Frederick Cancer Research and Development Center, MD 21702, USA.
authors.forename: J T
authors.initials: JT
authors.lastname: Holmund
authors.forename: W C
authors.initials: WC
authors.lastname: Kopp
authors.forename: R H
authors.initials: RH
authors.lastname: Wiltrout
authors.forename: D L
authors.initials: DL
authors.lastname: Longo
authors.forename: W J
authors.initials: WJ
authors.lastname: Urba
authors.forename: J E
authors.initials: JE
authors.lastname: Janik
authors.forename: M
authors.initials: M
authors.lastname: Sznol
authors.forename: K C
authors.initials: KC
authors.lastname: Conlon
authors.forename: R G
authors.initials: RG
authors.lastname: Fenton
authors.forename: R
authors.initials: R
authors.lastname: Hornung
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy / Q000556:secondary; D004334:Drug Administration Schedule; D005260:Female; D005419:Flavonoids / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000556:secondary; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D005419:Flavonoids; D007376:Interleukin-2; C049328:flavone acetic acid